SIGA Technologies

SIGA Technologies is a global health leader specializing in developing medicines to prevent and treat emerging infectious diseases with significant unmet medical needs. Their primary focus is on orthopoxviruses, such as smallpox and mpox, which pose a severe and imminent threat to global health. SIGA is dedicated to collaborating with governments, organizations, and foundations to combat outbreaks, whether they be natural, accidental, or intentional.

SIGA's flagship product is TPOXX®, a highly targeted antiviral treatment for orthopoxviruses. TPOXX has been approved by the FDA for smallpox, and the EMA and MHRA have approved it for smallpox, mpox, cowpox, and vaccinia complications. SIGA is committed to advancing TPOXX's regulatory approval for new indications and formulations, including post-exposure prophylaxis for smallpox, mpox treatment, and a pediatric formulation.

SIGA Technologies offers a comprehensive benefits package designed to support employees and their families. These benefits include fully funded medical, dental, and vision insurance for employees and eligible dependents, as well as supplemental benefits such as life and AD&D insurance, short and long-term disability coverage, healthcare savings plans, tuition reimbursement, professional development, and an employee assistance program. The company also fosters a supportive and inclusive work environment that encourages collaboration and professional development. Specific details regarding job flexibility, such as work-from-home options or flexible scheduling, are not mentioned in the provided content.

SIGA Technologies offers a comprehensive benefits package designed to support employees and their families. This includes fully funded medical, dental, and vision insurance for employees and eligible dependents, as well as supplemental benefits like life and AD&D insurance, short and long-term disability coverage, healthcare savings plans, tuition reimbursement, professional development opportunities, and an employee assistance program. These benefits aim to provide a supportive and inclusive work environment that promotes both personal and professional well-being.

SIGA Technologies is a global health leader dedicated to developing medicines that prevent and treat emerging infectious diseases with high unmet medical needs. They are particularly focused on developing best-in-class products to treat smallpox, mpox, and other orthopoxviruses, which are highly infectious and deadly. SIGA emphasizes proactive steps to prevent and stop outbreaks, working in partnership with governments, commercial organizations, and other stakeholders to ensure global health security.

SIGA fosters a supportive and inclusive culture that values compassion, innovation, and collaboration. They emphasize professional development and encourage multi-disciplinary teamwork to advance global health security. Their benefits package is designed to support employees and their families, fostering a thriving work environment where diversity is welcomed and respected.

SIGA Technologies fosters a workplace where every individual is respected and appreciated for the unique value they bring to the team, ensuring a professional environment that promotes inclusion and diversity of thought. They have policies and procedures in place to ensure equal employment opportunity without discrimination or harassment on the basis of race, color, religion, sex, sexual orientation, gender identity or expression, age, disability, marital status, citizenship, national origin, genetic information, or any other characteristics protected by law. SIGA strictly prohibits any discrimination, harassment, or retaliation for claims submitted in good faith.